Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rikke Medom Meldgaard"'
Autor:
Anthony K. Chan, Jayanthi Alamelu, Chris Barnes, Ampaiwan Chuansumrit, May‐Lill Garly, Rikke Medom Meldgaard, Guy Young
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 7, Pp 1101-1113 (2020)
Abstract Background/Objective We report the first analysis of an extended half‐life recombinant factor IX, nonacog beta pegol (N9‐GP), in previously untreated patients (PUPs) and minimally treated patients with hemophilia B. Methods Paradigm 6 (S
Externí odkaz:
https://doaj.org/article/9d21f64616344e6c8eaa8aafa8249a71
Autor:
Mindy L. Simpson, Rikke Medom Meldgaard, Carmen Escuriola Ettingshausen, Roshni Kulkarni, Robert Klamroth, David L. Cooper
Publikováno v:
Journal of Blood Medicine
Mindy L Simpson,1 Roshni Kulkarni,2 Carmen Escuriola Ettingshausen,3 Rikke Medom Meldgaard,4 David L Cooper,5 Robert Klamroth6 1Pediatric Hematology/Oncology, Rush University Medical Center, Chicago, IL, USA; 2Department of Pediatrics and Human Devel
Autor:
Roshni Kulkarni, Carmen Escuriola Ettingshausen, Rikke Medom Meldgaard, Paula Persson, Rajiv K. Pruthi, May-Lill Garly, Inga Hegemann, Robert Klamroth, Adam Cuker, Mindy L. Simpson
Publikováno v:
Research and Practice in Thrombosis and Haemostasis
Background and Objective Nonacog beta pegol (N9‐GP) and recombinant factor IX‐Fc fusion protein (rFIXFc) are extended half‐life rFIX compounds. We report the first single‐dose pharmacokinetic trial of N9‐GP and rFIXFc. Patients/Methods Para
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2953000801cca126514cb3b6a5df67a9
https://doi.org/10.5167/uzh-184576
https://doi.org/10.5167/uzh-184576